Profound Medical Corp. - common stock - Nakit Akışı (NASDAQ:PROF) | MetaTrader

Tam grafiği aç Full chart

Financials

Genel Bakış Tablolar İstatistikler

Çeyreklik Yıllık

İşletme faaliyetlerinden elde edilen nakit -20.57 M-22.36 M-25.8 M-22.3 M-23.45 M-38.21 M -38.51 M Yatırım faaliyetlerinden elde edilen nakit -350 K-593 K-593 K——-242 K — Finansman faaliyetlerinden elde edilen nakit 87.43 M5.95 M7.03 M1.46 M54.7 M41.14 M — Serbest nakit akışı -20.57 M-22.36 M-25.8 M-22.3 M-23.45 M-38.21 M -38.51 M

Haberler

Wall Street Analysts See a 59.68% Upside in Profound Medical (PROF): Can the Stock Really Move This High?

Profound Medical (PROF) Reports Q1 Loss, Tops Revenue Estimates

Indivior Pharmaceuticals Inc. (INDV) Q1 Earnings and Revenues Beat Estimates

Profound Medical (PROF) Surges 13.0%: Is This an Indication of Further Gains?

Top 3 Health Care Stocks That Are Set To Fly In March - BioMarin Pharmaceutical (NASDAQ:BMRN), Inspire Medical Systems (NYSE:INSP)

Profound Medical 4Ç 2025 kazancı beklentileri aştı, hisse yükseldi

Earnings call transcript: Profound Medical Q4 2025 EPS surprises, stock rises

Profound Medical (PROF) Reports Q4 Loss, Misses Revenue Estimates

ARS Pharmaceuticals, Inc. (SPRY) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Xeris Biopharma (XERS) Q4 Earnings and Revenues Surpass Estimates

Earnings Preview: Profound Medical (PROF) Q4 Earnings Expected to Decline

Aurinia Pharmaceuticals (AUPH) Tops Q4 Earnings and Revenue Estimates